PROFIT 500

#92

BioSyent

What the company does:

Acquires and licenses pharmaceutical products to bring to market in Canada

Growth 2010-15 (%): 815
Chief Executive: René Goehrum
Head Office: Toronto, Ont.
Website: www.biosyent.com
Founding Year: 2006
Revenue, 2015: 10–20 m
Exports (% of Revenue): 8
Employees, 2015 (full-time equivalent): 41
Stock Ticker: TSX-V:RX